Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|April 29, 2021
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid SyndromeDaniel E Pleguezuelo, Raquel Díaz-Simón, Oscar Cabrera-Marante, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseasesLaura Naranjo, Ora Shovman, Dolores Pérez, et al.
International Journal of Molecular Sciences|December 1, 2020
The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid SyndromeOscar Cabrera-Marante, Edgard Rodríguez de Frías, Manuel Serrano, et al.
Plos One|July 21, 2017
Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodiesCarlos Tortosa, Oscar Cabrera-Marante, Manuel Serrano, et al.
International Journal of Molecular Sciences|December 23, 2023
Quantification of Antiphospholipid Antibodies: The Importance of Using an Appropriate Methodology for Each Clinical ProfileOscar Cabrera-Marante, Sara Garcinuño, Daniel Enrique Pleguezuelo, et al.
Biomedicines|August 27, 2021
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting ActorFrancisco Javier Gil-Etayo, Sara Garcinuño, Antonio Lalueza, et al.
International Journal of Molecular Sciences|June 24, 2022
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 EvolutionSara Garcinuño, Francisco Javier Gil-Etayo, Esther Mancebo, et al.
Journal of Clinical Immunology|September 30, 2025
Malignancy and Autoimmune Susceptibility in Adult Patients with Human Inborn Errors of ImmunityAlejandro Segura-Tudela, Celia Nieto-López, Francisco Javier Bermejo-Olivera, et al.
Pageof 3